1. Home
  2. NEOG vs SYRE Comparison

NEOG vs SYRE Comparison

Compare NEOG & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEOG
  • SYRE
  • Stock Information
  • Founded
  • NEOG 1981
  • SYRE 2013
  • Country
  • NEOG United States
  • SYRE United States
  • Employees
  • NEOG N/A
  • SYRE N/A
  • Industry
  • NEOG Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEOG Health Care
  • SYRE Health Care
  • Exchange
  • NEOG Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • NEOG 1.0B
  • SYRE 1.1B
  • IPO Year
  • NEOG 1989
  • SYRE 2016
  • Fundamental
  • Price
  • NEOG $5.59
  • SYRE $14.97
  • Analyst Decision
  • NEOG Buy
  • SYRE Buy
  • Analyst Count
  • NEOG 3
  • SYRE 5
  • Target Price
  • NEOG $7.50
  • SYRE $55.00
  • AVG Volume (30 Days)
  • NEOG 5.6M
  • SYRE 455.7K
  • Earning Date
  • NEOG 10-09-2025
  • SYRE 11-06-2025
  • Dividend Yield
  • NEOG N/A
  • SYRE N/A
  • EPS Growth
  • NEOG N/A
  • SYRE N/A
  • EPS
  • NEOG N/A
  • SYRE N/A
  • Revenue
  • NEOG $894,661,000.00
  • SYRE N/A
  • Revenue This Year
  • NEOG N/A
  • SYRE N/A
  • Revenue Next Year
  • NEOG $1.86
  • SYRE N/A
  • P/E Ratio
  • NEOG N/A
  • SYRE N/A
  • Revenue Growth
  • NEOG N/A
  • SYRE N/A
  • 52 Week Low
  • NEOG $3.87
  • SYRE $10.91
  • 52 Week High
  • NEOG $17.96
  • SYRE $40.26
  • Technical
  • Relative Strength Index (RSI)
  • NEOG 51.72
  • SYRE 35.59
  • Support Level
  • NEOG $5.52
  • SYRE $15.80
  • Resistance Level
  • NEOG $5.84
  • SYRE $17.58
  • Average True Range (ATR)
  • NEOG 0.22
  • SYRE 0.75
  • MACD
  • NEOG -0.04
  • SYRE -0.19
  • Stochastic Oscillator
  • NEOG 36.11
  • SYRE 8.45

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: